
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New approaches to target RNA binding proteins
Ashley R. Julio, Keriann M. Backus
Current Opinion in Chemical Biology (2021) Vol. 62, pp. 13-23
Open Access | Times Cited: 59
Ashley R. Julio, Keriann M. Backus
Current Opinion in Chemical Biology (2021) Vol. 62, pp. 13-23
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
CysDB: a human cysteine database based on experimental quantitative chemoproteomics
Lisa M. Boatner, Maria F. Palafox, Devin K. Schweppe, et al.
Cell chemical biology (2023) Vol. 30, Iss. 6, pp. 683-698.e3
Open Access | Times Cited: 54
Lisa M. Boatner, Maria F. Palafox, Devin K. Schweppe, et al.
Cell chemical biology (2023) Vol. 30, Iss. 6, pp. 683-698.e3
Open Access | Times Cited: 54
Remodeling oncogenic transcriptomes by small molecules targeting NONO
Stefan G. Kathman, Seong Joo Koo, Garrett L. Lindsey, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 7, pp. 825-836
Open Access | Times Cited: 46
Stefan G. Kathman, Seong Joo Koo, Garrett L. Lindsey, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 7, pp. 825-836
Open Access | Times Cited: 46
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
Phei Er Saw, Erwei Song
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101555-101555
Open Access | Times Cited: 16
Phei Er Saw, Erwei Song
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101555-101555
Open Access | Times Cited: 16
HuR as a molecular target for cancer therapeutics and immune-related disorders
Mrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114442-114442
Open Access | Times Cited: 54
Mrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114442-114442
Open Access | Times Cited: 54
The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment
Margarita Bartish, Madelyn Jean Abraham, Christophe Gonçalves, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 408-425
Closed Access | Times Cited: 19
Margarita Bartish, Madelyn Jean Abraham, Christophe Gonçalves, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 408-425
Closed Access | Times Cited: 19
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
Sinan Ma, Jianai Ji, Yuanyuan Tong, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2990-3005
Open Access | Times Cited: 25
Sinan Ma, Jianai Ji, Yuanyuan Tong, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2990-3005
Open Access | Times Cited: 25
The aptamer-based RNA-PROTAC
Yan Xu, Yi Yuan, Dingqiang Fu, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117299-117299
Closed Access | Times Cited: 13
Yan Xu, Yi Yuan, Dingqiang Fu, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117299-117299
Closed Access | Times Cited: 13
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Huifang Wang, Runhua Zhou, Fushan Xu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 13
Huifang Wang, Runhua Zhou, Fushan Xu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 13
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
Takehisa Watanabe, Sanae Hayashi, Yan Zhaoyu, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 4, pp. 315-328
Closed Access | Times Cited: 5
Takehisa Watanabe, Sanae Hayashi, Yan Zhaoyu, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 4, pp. 315-328
Closed Access | Times Cited: 5
PD-L1 at the crossroad between RNA metabolism and immunosuppression
Axel Arthur, Sanae Nejmi, Don‐Marc Franchini, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 7, pp. 620-632
Closed Access | Times Cited: 4
Axel Arthur, Sanae Nejmi, Don‐Marc Franchini, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 7, pp. 620-632
Closed Access | Times Cited: 4
Cytoplasmic Regulation of the Poly(A) Tail Length as a Potential Therapeutic Target
Mercedes Fernández, Raúl Méndez
RNA (2025), pp. rna.080333.124-rna.080333.124
Closed Access
Mercedes Fernández, Raúl Méndez
RNA (2025), pp. rna.080333.124-rna.080333.124
Closed Access
RNA BINDING PROTEINS (RBPs) ON GENETIC STABILITY AND DISEASES
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, et al.
Global Medical Genetics (2025) Vol. 12, Iss. 1, pp. 100032-100032
Open Access
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, et al.
Global Medical Genetics (2025) Vol. 12, Iss. 1, pp. 100032-100032
Open Access
Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-Ray fragment screening
Louise Dunnett, Shweta Das, Vincenzo Venditti, et al.
Journal of Biological Chemistry (2025), pp. 108335-108335
Open Access
Louise Dunnett, Shweta Das, Vincenzo Venditti, et al.
Journal of Biological Chemistry (2025), pp. 108335-108335
Open Access
Regulatory Effects of RNA–Protein Interactions Revealed by Reporter Assays of Bacteria Grown on Solid Media
Guillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez‐Ràfols, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 175-175
Open Access
Guillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez‐Ràfols, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 175-175
Open Access
RNA modulation
Amanda L. Garner, Maurinne Bonnet, Charlotte A. Carozza, et al.
Elsevier eBooks (2025)
Closed Access
Amanda L. Garner, Maurinne Bonnet, Charlotte A. Carozza, et al.
Elsevier eBooks (2025)
Closed Access
Longitudinal and large-scale monitoring of transcriptome and RBP-RNA interactome in living cells by engineered protein nanocages
Yangming Wang, Lu‐Feng Hu, Gang Xie, et al.
Research Square (Research Square) (2025)
Open Access
Yangming Wang, Lu‐Feng Hu, Gang Xie, et al.
Research Square (Research Square) (2025)
Open Access
Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors
Krystel El Hage, Nicolas Babault, Olek Maciejak, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 12
Krystel El Hage, Nicolas Babault, Olek Maciejak, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 12
RNA binding proteins in senescence: A potential common linker for age-related diseases?
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Annalisa Barbieri, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101958-101958
Closed Access | Times Cited: 11
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Annalisa Barbieri, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101958-101958
Closed Access | Times Cited: 11
Targeting RNA ‐binding proteins with small molecules: Perspectives, pitfalls and bifunctional molecules
Qingxin Li, CongBao Kang
FEBS Letters (2023) Vol. 597, Iss. 16, pp. 2031-2047
Open Access | Times Cited: 11
Qingxin Li, CongBao Kang
FEBS Letters (2023) Vol. 597, Iss. 16, pp. 2031-2047
Open Access | Times Cited: 11
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 4
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 4
Decoding protein–RNA interactions using CLIP-based methodologies
Joy S. Xiang, Danielle Schafer, Katherine Rothamel, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 12, pp. 879-895
Closed Access | Times Cited: 4
Joy S. Xiang, Danielle Schafer, Katherine Rothamel, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 12, pp. 879-895
Closed Access | Times Cited: 4
Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness
Mariia Radaeva, Chia-Hao Ho, Ning Xie, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5687-5687
Open Access | Times Cited: 18
Mariia Radaeva, Chia-Hao Ho, Ning Xie, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5687-5687
Open Access | Times Cited: 18
Noncoding RNAs and RNA-binding proteins: emerging governors of liver physiology and metabolic diseases
Christian Sommerauer, Claudia Kutter
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1003-C1017
Closed Access | Times Cited: 17
Christian Sommerauer, Claudia Kutter
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1003-C1017
Closed Access | Times Cited: 17
Lin28 Regulates Cancer Cell Stemness for Tumour Progression
Zhuohui Lin, Mariia Radaeva, Artem Cherkasov, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4640-4640
Open Access | Times Cited: 16
Zhuohui Lin, Mariia Radaeva, Artem Cherkasov, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4640-4640
Open Access | Times Cited: 16
Spirocyclic Chromenopyrazole Inhibitors Disrupting the Interaction between the RNA‐Binding Protein LIN28 and Let‐7
Lydia Borgelt, Fubao Huang, Lisa Hohnen, et al.
ChemBioChem (2023) Vol. 24, Iss. 17
Open Access | Times Cited: 9
Lydia Borgelt, Fubao Huang, Lisa Hohnen, et al.
ChemBioChem (2023) Vol. 24, Iss. 17
Open Access | Times Cited: 9